---
title: "Larimar Therapeutics (LRMR.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/LRMR.US/norm.md"
symbol: "LRMR.US"
name: "Larimar Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/LRMR.US.md"
datetime: "2026-05-21T16:24:10.558Z"
locales:
  - [en](https://longbridge.com/en/quote/LRMR.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LRMR.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LRMR.US/norm.md)
---

# Larimar Therapeutics (LRMR.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.3281 | -0.7337 | -0.6092 | -0.4089 | -0.4578 |
| ROE | -100.33% | -230.28% | -147.43% | -79.30% | -74.11% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -29.61M | -62.50M | -47.71M | -26.18M | -29.28M |
| 营业利润 | -31.12M | -64.02M | -49.50M | -27.79M | -31.19M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 208.51M | 145.84M | 187.35M | 149.99M | 170.18M |
| 权益乘数 | 1.32 | 1.87 | 1.35 | 1.25 | 1.18 |
| 每股净资产 | 1.51 | 0.9369 | 1.62 | 1.87 | 2.25 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 200.38M | 136.85M | 175.44M | 138.52M | 157.53M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 2.42M | 2.69M | 2.98M | 3.27M | 3.50M |
| 净债务 | -196.61M | -132.78M | -171.09M | -133.91M | -152.66M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -44.61M | -38.53M | -28.75M | -19.38M | -26.54M |
| 投资现金流 | 29.00M | 34.00M | 33.02M | 18.84M | 14.45M |
| 融资现金流 | 108.11M | -201000.00 | 65.29M | - | - |
| 自由现金流 | -33.82M | -16.02M | -11.40M | -10.06M | -15.99M |
| 现金流充裕率 | - | - | -125013.04% | -102005.26% | -54163.27% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | 0.0000 | -23000.00 | -19000.00 | -49000.00 |